SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-442495"
 

Sökning: id:"swepub:oai:DiVA.org:uu-442495" > Transdermal Bupreno...

Transdermal Buprenorphine for Acute Pain in the Clinical Setting : A Narrative Review

Pergolizzi, Joseph V., Jr. (författare)
NEMA Res Inc, Naples, FL USA.
Magnusson, Peter (författare)
Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Karolinska Inst, Cardiol Res Unit, Dept Med, Stockholm, Sweden.
LeQuang, Jo Ann (författare)
NEMA Res Inc, Naples, FL USA.
visa fler...
Breve, Frank (författare)
Temple Univ, Sch Pharm, Dept Pharm Pract, Philadelphia, PA 19122 USA.
Mitchell, Kailyn (författare)
NEMA Res Inc, Naples, FL USA.
Chopra, Maninder (författare)
Decis Alternat LLC, Frederick, MD USA.
Varrassi, Giustino (författare)
Paolo Procacci Fdn, Rome, Italy.
visa färre...
NEMA Res Inc, Naples, FL USA Centrum för klinisk forskning, Gävleborg (creator_code:org_t)
Taylor & Francis, 2021
2021
Engelska.
Ingår i: Journal of Pain Research. - : Taylor & Francis. - 1178-7090. ; 14, s. 871-879
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • Transdermal buprenorphine is indicated for chronic pain management, but as its role in the clinical management of acute pain is less clear, this narrative review examines studies of the patch for acute pain, mainly in the postoperative setting. Although perhaps better known for its role in opioid rehabilitation programs, buprenorphine is also an effective analgesic that is a Schedule III controlled substance. Although buprenorphine is a partial agonist at the mu-opioid receptor, it is erroneous to think of the agent as a partial analgesic; it has full analgesic efficacy and unique attributes among opioids, such as a ceiling for respiratory depression and low "drug likeability" among those who take opioids for recreational purposes. Transdermal buprenorphine has been most thoroughly studied for acute pain control in postoperative patients. Postoperative pain follows a distinct and predictable trajectory depending on the type of surgery and patient characteristics. Overall, when the patch is applied prior to surgery and left in place for the prescribed seven days, it was associated with reduced postoperative pain, lower consumption of other analgesics, and patient satisfaction. Transdermal buprenorphine has been evaluated in clinical studies of patients undergoing gynecological surgery, hip fracture surgery, knee or hip arthroscopy/arthroplasty, shoulder surgery, and spinal surgery. Transdermal buprenorphine may also be appropriate pain medication for controlling pain during postsurgical orthopedic rehabilitation programs. Transdermal buprenorphine may result in typical opioid-associated side effects but with less frequency than other opioids. Despite clinical reservations about transdermal buprenorphine and its potential role in acute pain management in the clinical setting, clinical acceptance may be hampered by the fact that it is off-label and buprenorphine is better known as an opioid maintenance agent rather than an analgesic.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Ortopedi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Orthopaedics (hsv//eng)

Nyckelord

acute pain control
ceiling effect of buprenorphine
geriatric pain patients
gynecological surgery
hip arthroscopy
knee arthroscopy
opioid-associated side effects
orthopedic rehabilitation
orthopedic surgery
postoperative pain
spinal surgery
transdermal buprenorphine dosing

Publikations- och innehållstyp

ref (ämneskategori)
for (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy